N@N

Ed Arce Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Mar 20th, 2023

^{Published on 2024-10-28 02:20:37 - WOPRAI, Ed Arce}
 

Ed Arce of HC Wainwright & Co., Reiterated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $6 on, Mar 20th, 2023.

Ed has made no other calls on ABUS in the last 4 months.

There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, 0 agree with Ed's Rating of Hold.

This is the rating of the analyst that currently disagrees with Ed

---

• Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $6 on, Friday, March 3rd, 2023

Contributing Sources

---